YolTech Therapeutics

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of in vivo gene editing therapies focusing on serious diseases using lipid nanoparticle delivery systems. YolTech Therapeutics is based in Shanghai, China and was founded in 2021. Its last reported valuation was $136 million in Sep 2023. It has raised $75.1 million.

Last reported valuation
$135.8M
Oct 2026
Priced at
—
Total raised
$75.1M
Last round
—

Who backs YolTech Therapeutics?

14 investors
InvestorType
Green Pine Capital PartnersVenture capital
K2VCOther
Unity Ventures (China)Venture capital
Tianjin Venture CapitalVenture capital
Anhui Guokong CapitalOther
Hangzhou Huafang Chuangliang Investment ManagementOther
Wuxi AstraZeneca CICC Venture Capital PartnershipOther
Beijing Huafang Investment Co.—
Core Energy Ventures—
Decheng Capital—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

YolTech Therapeutics investors

14 investors are on record for YolTech Therapeutics, including Green Pine Capital Partners, K2VC, Unity Ventures (China) and Tianjin Venture Capital.

Free account
More of YolTech Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch YolTech Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like YolTech Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View